Our Story
In Correggio, Italy, early 1920, we find Giovanni Recordati working in a tiny laboratory installed in the back of his family’s pharmacy. With a passion to help people, he’s trying to find better combinations of existing treatments, as he believes more can be done to help those living with conditions that significantly impact their ability to live a full life.
Recordati started by focussing on where help was needed most – common illnesses that affect large populations day-to-day. The illnesses right in front of us, where we knew more could be done to help – from heart conditions, mental illness to prostate cancer. But as the world has grown around us, so has the need.
With the huge benefits of medical innovation, come discoveries of rare, devastating conditions, where for some, no treatment exists at all – with 7,000 known rare diseases, less than 10% have an available treatment option. So, since 2007, Recordati has also focused on helping the few who suffer from little known conditions such as Cushing’s disease, acromegaly, porphyria to rare cancers like high-risk neuroblastoma.
Today, almost 100 years and three generations later, Giovanni’s focus and determination lives on. His company, Recordati, is now a global pharmaceutical group, listed on the Italian stock exchange, with over 4,300 employees.
Every day, in every way, we do everything possible so that people can live full lives – we do this together, working closely with suppliers, partners and doctors from Brazil to the Far East, in around 150 countries. We will always continue to build with our people, planet, community, and our own roots, at our heart.
Underpinned by a history of strong financial delivery, we will continue to grow from within, capture opportunities within our own pipeline, and identify opportunities to bring in new treatments through partnerships & acquisitions across all our businesses.
